Literature DB >> 2678080

Present status of the medical irradiation facility at the Musashi reactor.

T Matsumoto1, O Aizawa, T Nozaki, T Sato.   

Abstract

Boron neutron capture therapy (BNCT) of malignant brain tumors has been efficiently performed since March 1977, and the first human case of malignant melanoma was also successfully treated on July 1987 in our reactor (Musashi reactor, TRIGA-II, 100 kW). To obtain both good irradiation field characteristics and a better irradiation facility, some tests and developments have been continued in accordance with the study of medical and biological irradiations. The results of these evaluations and a new approach are presented.

Entities:  

Mesh:

Year:  1989        PMID: 2678080     DOI: 10.1111/j.1600-0749.1989.tb00198.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  2 in total

1.  Fourier transform infrared (FTIR) spectrometry for the assay of polyhedral boron compounds in plasma and pharmaceutical formulations.

Authors:  Y Setiawan; T Rise; D E Moore
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

Review 2.  Fission reactor neutron sources for neutron capture therapy--a critical review.

Authors:  Otto K Harling; Kent J Riley
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.